Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10412754rdf:typepubmed:Citationlld:pubmed
pubmed-article:10412754lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:10412754lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10412754lifeskim:mentionsumls-concept:C0023823lld:lifeskim
pubmed-article:10412754lifeskim:mentionsumls-concept:C0027726lld:lifeskim
pubmed-article:10412754lifeskim:mentionsumls-concept:C0005791lld:lifeskim
pubmed-article:10412754lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:10412754pubmed:dateCreated1999-9-15lld:pubmed
pubmed-article:10412754pubmed:abstractTextThe pathogenic role of hyperlipidemia in long-standing nephrotic syndrome (NS) is known to be responsible for both the progression of glomerulosclerosis and tubulointerstitial injury, especially in focal segmental glomerulosclerosis (FGS).lld:pubmed
pubmed-article:10412754pubmed:languageenglld:pubmed
pubmed-article:10412754pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10412754pubmed:citationSubsetIMlld:pubmed
pubmed-article:10412754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10412754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10412754pubmed:statusMEDLINElld:pubmed
pubmed-article:10412754pubmed:monthJullld:pubmed
pubmed-article:10412754pubmed:issn0098-6577lld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:TakamitsuYYlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:UedaNNlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:KuwaharaTTlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:MikiSSlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:FujiiYYlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:ImaiEElld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:ImadaAAlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:TakemuraTTlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:PONGW SWSlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:TsubakiharaYYlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:MussIIlld:pubmed
pubmed-article:10412754pubmed:authorpubmed-author:HattaKKlld:pubmed
pubmed-article:10412754pubmed:issnTypePrintlld:pubmed
pubmed-article:10412754pubmed:volume71lld:pubmed
pubmed-article:10412754pubmed:ownerNLMlld:pubmed
pubmed-article:10412754pubmed:authorsCompleteYlld:pubmed
pubmed-article:10412754pubmed:paginationS122-5lld:pubmed
pubmed-article:10412754pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:meshHeadingpubmed-meshheading:10412754...lld:pubmed
pubmed-article:10412754pubmed:year1999lld:pubmed
pubmed-article:10412754pubmed:articleTitleLow density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.lld:pubmed
pubmed-article:10412754pubmed:affiliationKyoto University Graduate School of Medicine, Japan. muso@kuhp.kyoto-u.ac.jplld:pubmed
pubmed-article:10412754pubmed:publicationTypeJournal Articlelld:pubmed